imiquimod has been researched along with Hyperplasia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 8 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chu, C; Han, J; Huang, X; Li, X; Lin, Z; Wang, F; Xiong, Y; Xu, R | 1 |
| Chang, DC; Hsiao, CY; Hung, CF; Li, HJ; Pu, CM; Wu, NL | 1 |
| Di, T; Fu, J; Guo, J; Li, N; Li, P; Meng, Y; Wang, Y; Zhang, L; Zhao, J | 1 |
| He, C; Kaplan, N; Peng, H; Wang, J; Wang, L; Wang, S; Yang, W | 1 |
| Atwood, S; Chen, Z; Dai, X; Dragan, M; Greenberg, E; Gutierrez, G; Haensel, D; Han, W; Kessenbrock, K; Nguyen, Q; Pearlman, E; Shi, Y; Sun, P; Vu, R; Wu, J | 1 |
| Aoudjit, F; Berrazouane, S; Côté, MF; Defrêne, J; Esparza, N; Gobeil, S; Pagé, N; Tessier, PA | 1 |
| Bai, C; Chen, H; He, X; Huang, Z; Lei, Y; Li, Y; Liu, Z; Sheng, L; Tang, L; Tian, X; Wei, F; Xu, X; Yang, Y; Yu, B; Zhang, B; Zhou, X | 1 |
| Chan, TC; Chang, WY; Huang, WC; Krueger, JG; Lee, MS; Tsai, TF | 1 |
| Feng, B; He, S; Li, C; Liu, B; Liu, H; Lu, C; Su, Z; Tang, L; Wang, X; Xu, F; Zhao, J; Zheng, G; Zheng, X; Zhu, W; Zhu, Y | 1 |
| Fukami, S; Kai, H; Morita, M; Moriuchi, M; Nakano, Y; Piruzyan, M; Shuto, T; Suico, MA; Takada, M; Tsurekawa, Y | 1 |
| Carstens, E; Carstens, M; Domocos, DT; Follansbee, T; Han, D; Hwang, ST; Shi, Z; Wu, X; Yu, S; Zhou, Y | 1 |
| Challa, VS; Godugu, C; Pooladanda, V; Sunkari, S; Thatikonda, S | 1 |
| Fukami, K; Kanemaru, K; Matsuyuki, A; Nakamura, Y | 1 |
| Kang, KS; Kim, TY; Park, KH; Sah, SK; Yun, CO | 1 |
| Neuhaus, I; North, J; Valdebran, M | 1 |
15 other study(ies) available for imiquimod and Hyperplasia
| Article | Year |
|---|---|
Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis.
Topics: Animals; Disease Models, Animal; Eukaryotic Initiation Factor-4E; Humans; Hyperplasia; Imiquimod; Inflammation; Interleukin-17; Keratinocytes; Mice; Mice, Inbred BALB C; Psoriasis; Skin; Tumor Necrosis Factor-alpha | 2023 |
Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Topics: Animals; Antimicrobial Cationic Peptides; Chemokine CCL20; Disease Models, Animal; Down-Regulation; Epidermis; Flavonoids; Humans; Hyperplasia; Imiquimod; Inflammation; Interleukin-17; Interleukin-22; Interleukins; Keratinocytes; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; NF-kappa B; Phosphorylation; Psoriasis; RNA, Messenger; Skin; Tumor Necrosis Factor-alpha | 2020 |
Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1β/IL-23p40 production.
Topics: Animals; Anxiety; Dendritic Cells; Dermatitis; Emotions; Epidermis; Hyperplasia; Imiquimod; Inflammation; Interleukin-12 Subunit p40; Interleukin-1beta; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Nociceptors; Psoriasis; Receptors, Neurokinin-1; Stress, Psychological; Substance P; Up-Regulation | 2020 |
Autophagy plays a positive role in induction of epidermal proliferation.
Topics: Animals; Autophagy; Cell Cycle; Cell Proliferation; Cells, Cultured; Epidermis; Gene Expression; Humans; Hyperplasia; Imiquimod; Inflammation; Keratinocytes; Mice; Signal Transduction; Skin | 2020 |
OVOL1 Regulates Psoriasis-Like Skin Inflammation and Epidermal Hyperplasia.
Topics: Animals; Cell Differentiation; Cell Proliferation; Disease Models, Animal; DNA-Binding Proteins; Epidermis; Female; Humans; Hyperplasia; Imiquimod; Interleukin-1alpha; Male; Mice, Knockout; Psoriasis; RNA-Seq; Signal Transduction; Single-Cell Analysis; Transcription Factors; Up-Regulation | 2021 |
Deletion of
Topics: Animals; Antibodies, Blocking; Calgranulin A; Calgranulin B; Cells, Cultured; Disease Models, Animal; Humans; Hyperplasia; Imiquimod; Interleukin-17; Mice, Inbred C57BL; Mice, Knockout; Psoriasis; Skin; Th17 Cells | 2021 |
Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Disease Models, Animal; Epidermis; Eriobotrya; Humans; Hyperplasia; Imiquimod; Inflammation; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Pentacyclic Triterpenes; Plant Leaves; Psoriasis; Th17 Cells | 2021 |
Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Antipruritics; Capsaicin; Dermatitis; Disease Models, Animal; Epidermis; Female; Hyperplasia; Imiquimod; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2021 |
Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT3.
Topics: Animals; Cell Line; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; Epidermis; Humans; Hyperplasia; Imiquimod; Keratinocytes; Male; Mice, Inbred C57BL; Phenanthrenes; Psoriasis; STAT3 Transcription Factor | 2018 |
Mild electrical stimulation with heat shock reduces inflammatory symptoms in the imiquimod-induced psoriasis mouse model.
Topics: Animals; beta-Defensins; Calgranulin A; Calgranulin B; CD3 Complex; Cell Line; Cell Movement; Cell Proliferation; Combined Modality Therapy; Disease Models, Animal; Electric Stimulation Therapy; Female; Gene Expression; Humans; Hyperplasia; Hyperthermia, Induced; Imiquimod; Interleukin-17; Keratinocytes; Mice; Pancreatitis-Associated Proteins; Psoriasis; RNA, Messenger; Skin; T-Lymphocytes | 2018 |
TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
Topics: Animals; Cytokines; Disease Models, Animal; Epidermis; Female; Humans; Hyperplasia; Imiquimod; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Psoriasis; TRPV Cation Channels; Water Loss, Insensible | 2018 |
Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms.
Topics: Ambroxol; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Humans; Hyperplasia; Imiquimod; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Psoriasis; RAW 264.7 Cells; Signal Transduction; Skin | 2019 |
Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Topics: Aminoquinolines; Animals; Cell Line; Disease Models, Animal; Epidermis; Female; Humans; Hyperplasia; Imiquimod; Interleukin-17; Interleukin-22; Interleukins; Keratinocytes; Male; Membrane Glycoproteins; Mice; Mice, Mutant Strains; Obesity; Pancreatitis-Associated Proteins; Phosphatidylinositol 3-Kinases; Proteins; Psoriasis; Toll-Like Receptor 7 | 2015 |
Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
Topics: Aminoquinolines; Animals; Cytokines; Dendritic Cells; Disease Models, Animal; Gene Expression; Humans; Hyperplasia; Imiquimod; Inflammation Mediators; Janus Kinases; Lymph Nodes; Lymphocyte Activation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mitogen-Activated Protein Kinases; Mucolipidoses; Neutrophil Infiltration; NF-kappa B; Psoriasis; Reactive Oxygen Species; Severity of Illness Index; Signal Transduction; Skin; Spleen; STAT Transcription Factors; Superoxide Dismutase; T-Lymphocytes; Toll-Like Receptor 7; Transduction, Genetic | 2016 |
Pseudocarcinomatous Epithelial Hyperplasia Induced by Imiquimod: A Mimic of Cutaneous Squamous Cell Carcinoma.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Squamous Cell; Diagnosis, Differential; Facial Dermatoses; Female; Forehead; Humans; Hyperplasia; Imiquimod | 2017 |